🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Millions of people each year sustain injuries, have tumors surg...
Status
Recruiting
Location
Johns Hopkins University School of Medicine
Start Date
2011-07-21
Trial ID
NCT01459107
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Status
Completed
Location
UAB HIVTR-CCR5 Non-Network CRS
Start Date
2017-01-01
Trial ID
NCT02741323
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This is a Phase III, randomized, unblinded, multicenter, prospective compar...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2011-01
Trial ID
NCT01278927
Treatments Being Tested
This is a multicentre, open-label, phase II study of ibrutinib 560 mg in co...
Status
Unknown
Location
National University Hospital Singapore
Start Date
2016-12-13
Trial ID
NCT02955628
Treatments Being Tested
This study evaluates the addition of "Kidney Solid Organ Rejection Test" (k...
Status
Completed
Location
National Institute of Medical Sciences and Health Salvador Zubiran
Start Date
2014-09
Trial ID
NCT02581436
Treatments Being Tested
The goal of this clinical research study is to learn if giving romidepsin b...
Status
Completed
Location
The Ohio State University Cancer Center
Start Date
2017-12-08
Trial ID
NCT02512497
Treatments Being Tested
This is a phase II open label trial designed to evaluate the efficacy of Ta...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2014-12
Trial ID
NCT02206035
Treatments Being Tested
This is a phase II study where patients will undergo isatuximab and lenalid...
Status
Recruiting
Location
University of Illinois at Chicago
Start Date
2023-01-05
Trial ID
NCT05344833
Treatments Being Tested